Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma

由 Lee, N.P., Poon, R.T.P., Shek, F.H., Ng, I.O.L., Luk, J.M.
出版 2016

MiR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma

由 Liu, A.M., Xu, Z., Shek, F.H., Wong, K.-F., Lee, N.P., Poon, R.T., Chen, J., Luk, J.M.
出版 2014

Anti-cadherin-17 antibody modulates beta-catenin signaling and tumorigenicity of hepatocellular carcinoma

由 Wang Y., Shek F.H., Wong K.F., Liu L.X., Zhang X.Q., Yuan Y., Khin E., Hu M.-Y., Wang J.H., Poon R.T.P., Hong W., Lee N.P., Luk J.M.
出版 2019

DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival

由 Luk, J.M., Burchard, J., Zhang, C., Liu, A.M., Wong, K.F., Shek, F.H., Lee, N.P., Fan, S.T., Poon, R.T., Ivanovska, I., Philippar, U., Cleary, M.A., Buser, C.A., Shaw, P.M., Lee, C.-N., Tenen, D.G., Dai, H., Mao, M.
出版 2014